These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 590598)

  • 1. The interactions of ticlopidine and aspirin in normal subjects.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    J Int Med Res; 1977; 5(6):405-11. PubMed ID: 590598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of platelet aggregation induced by platelet activating factor (PAF) after administration of ticlopidine or aspirin.
    Lecrubier C; Conard J; Horellou MH; Samama M
    Agents Actions; 1983 Feb; 13(1):77-80. PubMed ID: 6858789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation].
    Sakata T; Kobayashi K; Katayama Y; Takada T; Matsuyama T
    Rinsho Byori; 1991 Mar; 39(3):315-20. PubMed ID: 2051607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent inhibition of human platelet aggregation by prasugrel and its interaction with aspirin in healthy subjects.
    Jakubowski JA; Payne CD; Weerakkody GJ; Brandt JT; Farid NA; Li YG; Naganuma H; Lachno DR; Winters KJ
    J Cardiovasc Pharmacol; 2007 Mar; 49(3):167-73. PubMed ID: 17414229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombotic effects of ticlopidine, acetylsalicyclic acid and dipyridamole in vascular shunt model in rats.
    Ashida S; Sakuma K; Abiko Y
    Thromb Res; 1980 Mar; 17(5):663-71. PubMed ID: 7385100
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet aggregation measured in rabbit whole blood: in vitro study of 3 aggregating agents and ex vivo inhibition by aspirin and ticlopidine.
    Chevolet C; Grosdent JC; Reiters GM; Dresse A
    Arch Int Pharmacodyn Ther; 1982 Oct; 259(2):310-1. PubMed ID: 6817725
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of ticlopidine, a new platelet aggregation inhibitor in man.
    Thebault JJ; Blatrix CE; Blanchard JF; Panak EA
    Clin Pharmacol Ther; 1975 Oct; 18(4):485-90. PubMed ID: 1100310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
    Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 10. Mode of action of ticlopidine in inhibition of platelet aggregation in the rat.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Apr; 41(2):436-49. PubMed ID: 224522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ticlopidine on human platelet responsiveness ex vivo: comparison with aspirin.
    Nunn B; Lindsay R
    Thromb Res; 1980 Jun; 18(6):807-813. PubMed ID: 7414564
    [No Abstract]   [Full Text] [Related]  

  • 13. The lack of augmentation by aspirin of inhibition of platelet reactivity by ticlopidine.
    Farrell TP; Hayes KB; Sobel BE; Schneider DJ
    Am J Cardiol; 1999 Mar; 83(5):770-4. PubMed ID: 10080435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of recurrent cerebral infarction with adenosine diphosphate- and collagen-induced platelet aggregation in patients treated with ticlopidine and/or aspirin.
    Abumiya T; Houkin K
    J Stroke Cerebrovasc Dis; 2011; 20(4):319-23. PubMed ID: 20634093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.
    Pulcinelli FM; Pignatelli P; Celestini A; Riondino S; Gazzaniga PP; Violi F
    J Am Coll Cardiol; 2004 Mar; 43(6):979-84. PubMed ID: 15028353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of ticlopidine on platelet function in normal volunteers and in patients with platelet hyperaggregability in vitro.
    Knudsen JB; Gormsen J
    Thromb Res; 1979; 16(5-6):663-71. PubMed ID: 524316
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in platelet aggregation during treatment with acetylsalicylic acid. Sensitivity of various aggregating agents].
    Lecrubier C; Conard J; Horellou MH; Kher A; Samama M
    Therapie; 1982; 37(5):581-6. PubMed ID: 7179328
    [No Abstract]   [Full Text] [Related]  

  • 19. In vivo study of platelet aggregation in rats.
    Pinon JF
    J Pharmacol Methods; 1984 Sep; 12(2):79-84. PubMed ID: 6536819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ticlopidine and acetylsalicylic acid on generation of prostaglandin I2-like substance in rat arterial tissue.
    Ashida S; Abiko Y
    Thromb Res; 1978 Nov; 13(5):901-8. PubMed ID: 369031
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.